Effects of short-term CPAP withdrawal on neurobehavioral performance in patients with obstructive sleep apnea

Sleep

Volumn 29, Issue 4, 2006, Pages 545-552

  Yang, Qiao ^a,b   Phillips, Craig L ^a,c   Melehan, Kerri L ^a,b   Rogers, Naomi L ^a,b   Paul Seale, J ^b,d   Grunstein, Ronald R ^a,b,e  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

^d University of Sydney   (Australia)

^e NONE   (Australia)

Author keywords

Autonomic activity; Cognitive function; CPAP; Neurobehavioral performance; OSA

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; AIRWAY OBSTRUCTION; ALERTNESS; AROUSAL; ARTICLE; BLOOD VOLUME; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DISEASE EXACERBATION; FEMALE; FINGER; HUMAN; HYPOXEMIA; MALE; MOOD; NIGHT; OXYGENATION; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PSYCHOMOTOR VIGILANCE TASK; RATING SCALE; RECURRENCE RISK; SLEEP APNEA SYNDROME; SLEEP DISORDERED BREATHING; SOMNOLENCE; TONOMETRY; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; UNIVERSITY HOSPITAL;

EID: 33745802788     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/29.4.545     Document Type: Article

References (45)

1. McArdle N, Douglas NJ. Effect of continuous positive airway pressure on sleep architecture in the sleep apnea-hypopnea syndrome: a randomized controlled trial. Am J Respir Crit Care Med 2001;164:1459-63.
2. Ferini-Strambi L, Baietto C, Di Gioia MR, et al. Cognitive dysfunction in patients with obstructive sleep apnea (OSA): partial reversibility after continuous positive airway pressure (CPAP). Brain Res Bull 2003;61:87-92.
3. Grote L, Hedner J, Grunstein R, Kraiczi H. Therapy with nCPAP: incomplete elimination of Sleep Related Breathing Disorder. Eur Respir J 2000;16:921-7.
4. Engleman HM, Wild MR. Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome (SAHS). Sleep Med Rev 2003;7:81-99.
5. Banerjee D, Yee B, Grunstein R. Airline acceptability of in-flight CPAP machines-flight, fright, or fight? Sleep 2003;26:914-5.
6. Leech JA, Onal E, Lopata M. Nasal CPAP continues to improve sleep-disordered breathing and daytime oxygenation over long-term follow-up of occlusive sleep apnea syndrome. Chest 1992;102:165-5.
7. Kribbs NB, Pack AI, Kline LR, et al. Effects of one night without nasal CPAP treatment on sleep and sleepiness in patients with obstructive sleep apnea. Am Rev of Respir Dis 1993;147:1162-8.
8. Sforza E, Lugaresi E. Daytime sleepiness and nasal continuous positive airway pressure therapy in obstructive sleep apnea syndrome patients: effects of chronic treatment and 1-night therapy withdrawal. Sleep 1995;18:195-201.
9. Grunstein RR, Stewart DA, Lloyd H, Akinci M, Cheng N, Sullivan CE. Acute withdrawal of nasal CPAP in obstructive sleep apnea does not cause a rise in stress hormones. Sleep 1996;19:774-82.
10. Noseda A, Kempenaers C, Kerkhofs M, Houben JJ, Linkowski P. Sleep apnea after 1 year domiciliary nasal-continuous positive airway pressure and attempted weight reduction. Potential for weaning from continuous positive airway pressure. Chest 1996;109:138-43.
11. Boudewyns A, Sforza E, Zamagni M, Krieger J. Respiratory effort during sleep apneas after interruption of long-term CPAP treatment in patients with obstructive sleep apnea. Chest 1996;110:120-27.
12. Fiz JA, Abad J, Ruiz J, Riera M, Izquierdo J, Morera J. nCPAP treatment interruption in OSA patients. Respir Med 1998;92:28-31.
13. Bonsignore MR, Parati G, Insalaco G, et al. Continuous positive airway pressure treatment improves baroreflex control of heart rate during sleep in severe obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2002;166:279-86.
14. Marrone O, Salvaggio A, Bonsignore MR, Insalaco G, Bonsignore G. Blood pressure responsiveness to obstructive events during sleep after chronic CPAP. Eur Respir J 2003;21:509-14.
15. Ip MS, Tse HF, Lam B, Tsang KW, Lam WK. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 2004;169:348-53.
16. Belenky G, Wesensten NJ, Thorne DR, et al. Patterns of performance degradation and restoration during sleep restriction and subsequent recovery: a sleep dose-response study. J Sleep Res 2003;12:1-12.
17. Van Dongen HP, Maislin G, Mullington JM, Dinges DF. The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep 2003;26:117-26.
18. Catcheside PG, Chiong SC, Mercer J, Saunders NA, McEvoy RD. Noninvasive cardiovascular markers of acoustically induced arousal from non-rapid-eye- movement sleep. Sleep 2002;25:797-804.
19. O'Donnell CP, Allan L, Atkinson P, Schwartz AR. The effect of upper airway obstruction and arousal on peripheral arterial tonometry in obstructive sleep apnea. Am J Respir Crit Care Med 2002;166:965-71.
20. Vgontzas AN, Bixler EO, Chrousos GP. Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 2005;9:211-24.
21. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-5.
22. American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999;22:667-89.
23. Rechtschaffen A, Kales A. A Manual of Standardized Terminology. Techniques and Scoring System for Sleep Stages of Human Subjects. In: National Institute of Health. Washington, DC: U.S.: Government Printing Office; 1968.
24. EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 1992;15:173-84.
25. Lavie P, Shlitner A, Sheffy J, Schnall RP. Peripheral arterial tonometry: a novel and sensitive non-invasive monitor of brief arousals during sleep. Isr Med Assoc J 2000;2:246-7.
26. Tauman R, O'Brien LM, Mast BT, Holbrook CR, Gozal D. Peripheral arterial tonometry events and electroencephalographic arousals in children. Sleep 2004;27:502-6.
27. Bennett LS, Stradling JR, Davies RJ. A behavioural test to assess daytime sleepiness in obstructive sleep apnoea. J Sleep Res 1997;6:142-5.
28. Krieger AC, Ayappa I, Norman RG, Rapoport DM, Walsleben J. Comparison of the maintenance of wakefulness test (MWT) to a modified behavioral test (OSLER) in the evaluation of daytime sleepiness. J Sleep Res 2004;13:407-11.
29. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988;75:800-02.
30. Cohen J. Statistical power analysis for the behavioral sciences: Lawrence Earlbaum Associates; 1988.
31. Bonnet MH. The effect of sleep fragmentation on sleep and performance in younger and older subjects. Neurobio of Aging 1989;10:21-5.
32. Series F, Cormier Y, La Forge J, Desmeules M. Mechanisms of the effectiveness of continuous positive airway pressure in obstructive sleep apnea. Sleep 1992;15:S47-9.
33. Berry R, Kouchi K, Der D, Dickel M, Light R. Sleep apnea impairs the arousal response to airway occlusion. Chest 1996;109:1490-6.
34. Waters KA, Tinworth KD. Habituation of arousal response after intermittent hypercapnic hypoxia in piglet. Am J Respir Crit Care Med 2005;171:1305-11.
35. Brooks D, Horner RL, Kimoff RJ, Kozar LF, Render-Teixeira CL, Phillipson EA. Effect of obstructive sleep apnea versus sleep fragmentation on responses to airway occlusion. Am J Respir Crit Care Med 1997;155:1609-17.
36. Fleetham JA. Upper airway imaging in relation to obstructive sleep apnea. Clin Chest Med 1992;13:399-416.
37. Mortimore IL, Kochhar P, Douglas NJ. Effect of chronic continuous positive airway pressure (CPAP) therapy on upper airway size in patients with sleep apnoea/hypopnoea syndrome. Thorax 1996;51:190-2.
38. Pillar G, Bar A, Shlitner A, Schnall R, Shefy J, Lavie P. Autonomic arousal index: an automated detection based on peripheral arterial tonometry. Sleep 2002;25:543-9.
39. Gozal E, Shah ZA, Pequignot JM, et al. Tyrosine Hydroxylase Expression and Activity in the Rat Brain: Differential Regulation Following Long-term Intermittent or Sustained Hypoxia. J Appl Physiol 2005.
40. Van Dongen HP, Vitellaro KM, Dinges DF. Individual differences in adult human sleep and wakefulness: leitmoif for a research agenda. Sleep 2005;28:479-96.
41. Weaver TE. Outcome measurement in sleep medicine practice and research. Part 2: assessment of neurobehavioral performance and mood. Sleep Med Rev 2001;5:223-36.
42. Row BW, Kheirandish L, Neville JJ, Gozal D. Impaired spatial learning and hyperactivity in developing rats exposed to intermittent hypoxia. Pediatr Res 2002;52:449-53.
43. Gozal D, Row BW, Kheirandish L, et al. Increased susceptibility to intermittent hypoxia in aging rats: changes in proteasomal activity, neuronal apoptosis and spatial function. J Neurochem 2003;86:1545-52.
44. Vgontzas AN, Zoumakis E, Bixler EO, et al. Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab 2004;89:2119-26.
45. Dorrian J, Rogers NL, Dinges DF. Psychomotor vigilance performance: neurocognitive assay sensitive to sleep loss. In: Kushida CA, ed. Sleep Deprivation Clinical Issues, Pharmacology, and Sleep Loss Effects. New York: Marcel Dekker; 2005:39-70.